Latest Blog Posts Tagged "CERE-120"
May 21, 2013
In April, we reported on disappointing clinical trial results of Ceregene's trophic factor therapy CERE-120. Today, additional data is announced that could be instructional moving forward.
April 26, 2013
Dave Iverson reports on recent disappointing clinical trial results of Ceregene's trophic factor therapy CERE-120.
April 19, 2013
Ceregene today announced disappointing results from its second Phase 2 trial of CERE-120, an experimental gene therapy treatment for PD. The drug's future development is unclear.
Ceregene: Early Indications that Trophic Factor Biochemically Active in Brain Long After Gene Therapy; More Research Needed
June 05, 2012
Biotech company Ceregene announced evidence of increased levels of the trophic factor neurturin in the brain, for four-plus years following CERE-120 gene therapy to treat Parkinson's disease.